Healthcare
Live Price
Offline$4.00
+0.00% today
1Y Change
-20.32%
Window
Jun 20, 2025 → Jun 4, 2026
Coverage: 247 bars · Jun 20, 2025 → Jun 4, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
RetinalGenix Technologies Inc. (RTGN) is a Healthcare stock with a market cap of $80.00M and listed on OTC. The stock last traded around $4.00 and down 20.3% across the available one-year price window (Jun 20, 2025 → Jun 4, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +45.8%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +45.8%, free cash flow +24.7% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines RTGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RTGN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RTGN Max Drawdown
-36.25%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RTGN and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.